Skip to content

Clinical trials

Generalized Anxiety Disorder trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20142
20173
20201
20232
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Unknown status2
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical Research Council Cognition and Brain Sciences Unit2
University of Manchester2
AstraZeneca1
Brunel University1
Cerina Therapeutics1
Definium Therapeutics US, Inc.1
Eli Lilly and Company1
Engrail Therapeutics INC1
Norfolk and Suffolk NHS Foundation Trust1
Silver Cloud Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder15
Anxiety Disorders8
Panic Disorder3
Major Depressive Disorder2
Phobia, Social2
Agoraphobia1
Attention Deficit Disorder with Hyperactivity1
Autistic Disorder1
Bipolar Disorder1
Depressive Disorder1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.